---
category: news
title: "Kiromic Announces the Filing of Key European Patents for Its Chimeric PD-1 (chPD1) Target"
excerpt: "Kiromic Biopharma, Inc. (NASDAQ:KRBP), a target discovery and gene-editing company utilizing artificial intelligence and proprietary neural network platform with a"
publishedDateTime: 2021-01-05T01:35:00Z
originalUrl: "https://www.benzinga.com/pressreleases/21/01/b19011075/kiromic-announces-the-filing-of-key-european-patents-for-its-chimeric-pd-1-chpd1-target"
webUrl: "https://www.benzinga.com/pressreleases/21/01/b19011075/kiromic-announces-the-filing-of-key-european-patents-for-its-chimeric-pd-1-chpd1-target"
ampWebUrl: "https://amp.benzinga.com/amp/content/19011075"
cdnAmpWebUrl: "https://amp-benzinga-com.cdn.ampproject.org/c/s/amp.benzinga.com/amp/content/19011075"
type: article
quality: 15
heat: 15
published: false

provider:
  name: Benzinga.com
  domain: benzinga.com

topics:
  - AI in Healthcare
  - AI

secured: "NB8wJBnQ0Vhc49GEtkSDXrjAwQoki+i9uBXuLstPKMonkB78nuETvHmjBoD967VYL+OTy2WX4rD+Lkr7VcBbO20D6mtitBxH3CYHKEfVsEiaaq22ZEcpiGgdDSPu6KcRJgKyDdu/LMZDfanSHTqzfMl/zWqqTXz6pu093wDPSsUVmh/7h6eCRVPY9XvxownHyUU4Po8gM3ghzxNByU96yS1DMOOOf2M7Vk8ADJpAMl5NfADEoXWgB4rBOPyO3gdzl83rJEnshbReCq5wCE4xQBsqCGtV9VTUSQnR6Z5Xkxu9NeXpER51YnCfnQTNlYfxmxzNgbE/ycnFXZSM52ot+Tp8FQ4CQDyWaCz77ypz6EI=;hzpIYO8UCNrQIk4JjGkL8A=="
---

